- Business
- Republic Technologies Inc. (CSE: DOCT) is a publicly traded technology company that integrates Ethereum blockchain infrastructure into the global economy by operating proprietary validator and attestation networks to secure network data integrity for applications across sectors including financial services, healthcare, supply chain management and regulatory compliance. The company provides Ethereum-based infrastructure services such as validator-as-a-service for maintaining ETH validators to secure the network and generate yield revenue; node attestation for high uptime and maximizing consensus rewards; staking and yield generation through network security and on-chain fixed income instruments; re-staking and advanced validation to monetize validator weight in EigenLayer and shared security layers; and compliance and slashing-insurance wrappers with policy-audited operations, distributed validator technology redundancy and pooled insurance to meet institutional risk and regulatory standards. Backed by an ETH-denominated corporate treasury that strategically accumulates ETH through dollar-cost averaging, OTC blocks and targeted purchases while recycling staking revenues and optimizing collateral for non-dilutive ETH-per-share growth, Republic Technologies targets institutional and public market investors seeking compliant exposure to Ethereum's proof-of-stake ecosystem. Founded in 2006 as Beyond Medical Technologies Inc. and rebranded following a strategic pivot to blockchain infrastructure, the company maintains its head office in Vancouver, British Columbia, Canada, with global operations aligned to Ethereum's decentralized network. In November 2025, Republic Technologies entered a definitive investment agreement for a secured convertible note facility of up to US$100 million with an institutional investor, allocating approximately 90% of net proceeds to ETH acquisitions supporting validator infrastructure and attestation services; in September 2025, it partnered with FalconX for Ethereum validator operations and with QCP Capital for treasury strategies; and earlier in 2025, it reported robust H1 progress ahead of the rebranding.